Pharmacotherapy and Pharmaceutical Care

University of Groningen > Faculty of Science and Engineering > Faculty Board FSE > FSE Research > Groningen Research Institute of Pharmacy > Pharmacotherapy and Pharmaceutical Care

  1. 2020
  2. Fedorenko, O. Y., Paderina, D. Z., Loonen, A. J. M., Pozhidaev, I., Boiko, A. S., Kornetova, E. G., ... Ivanova, S. A. (2020). Association of ANKK1 polymorphism with antipsychotic-induced hyperprolactinemia. Human Psychopharmacology, [2737]. https://doi.org/10.1002/hup.2737
  3. 2019
  4. Ivanova, S. A., Boiko, A. S., Mednova, I. A., Kornetova, E. G., & Loonen, A. J. M. (2019). P.374 Cortisol and DHEAS related to metabolic side effects in patients with schizophrenia. European Neuropsychopharmacology, 29(Supp. 6), S265-S266. https://doi.org/10.1016/j.euroneuro.2019.09.389
  5. Boiko, A. S., Mednova, I. A., Kornetova, E. G., Semke, A. V., Bokhan, N. A., Loonen, A. J. M., & Ivanova, S. A. (2019). Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia. Heliyon, 5(7), [e02033]. https://doi.org/10.1016/j.heliyon.2019.e02033
  6. 2018
  7. Hilgersom, W., Van Hunsel, F., & Van Puijenbroek, E. (2018). Importance of background information of the national immunization program for children in vaccine signal detection. 1246. Abstract from 18th ISoP Annual Meeting “Pharmacovigilance without borders” Geneva, Switzerland, 11–14 November, 2018, Geneva, Switzerland. https://doi.org/10.1007/s40264-018-0719-2
  8. Rolfes, L., Hek, K., Verheij, R., Van Dijk, L., & Van Puijenbroek, E. (2018). Monitor the benefit and risk of medicines in primary care; Building a bridge between daily practice and research. 1147. Abstract from 18th ISoP Annual Meeting “Pharmacovigilance without borders” Geneva, Switzerland, 11–14 November, 2018, Geneva, Switzerland. https://doi.org/10.1007/s40264-018-0719-2
  9. 2017
  10. Geers, L. M., Pozhidaev, I. V., Ivanova, S. A., Freidin, M. B., Cohen, D., Boiko, A. S., ... Loonen, A. J. M. (2017). Association between P-glycoprotein polymorphisms and antipsychotic drug-induced hyperprolactinemia. European Neuropsychopharmacology, 27(Supplement 4), S956. https://doi.org/10.1016/S0924-977X(17)31689-9
  11. Nuntamool, N., Ngamsamut, N., Vanwong, N., Puangpetch, A., Chamnanphon, M., Hongkaew, Y., ... Sukasem, C. (2017). Pharmacogenomics and Efficacy of Risperidone Long-Term Treatment in Thai Autistic Children and Adolescents. Basic & clinical pharmacology & toxicology, 121(4), 316-324. https://doi.org/10.1111/bcpt.12803
  12. Kovačević, S. V., Miljković, B., Ćulafić, M., Kovačević, M., Golubović, B., Jovanović, M., ... de Gier, J. J. (2017). Evaluation of drug-related problems in older polypharmacy primary care patients. Journal of Evaluation in Clinical Practice, 23(4), 860-865. https://doi.org/10.1111/jep.12737
Previous 1 2 3 4 5 6 7 8 ...25 Next

ID: 32723